UPC APP 34218/2025

—

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
Genevant Sciences GmbH
Arbutus Biopharma Corporation
Reps: Markus van Gardingen
Respondents
Moderna, Inc.
Moderna Belgium S.R.L.
Moderna Denmark ApS
Moderna Sweden AB
Moderna Switzerland GmbH
Moderna Portugal Unipessoal LDA
ModernaTX, Inc.
Moderna Norway AS
Moderna Poland SP. Z.O.O.
Reps: Ruben Laddé
Division: The Hague LD
Judges: —
Language: —
First decided: Aug 13, 2025

Decisions

2025-08-13
Generic application
The Hague Local Division considered Genevant/Arbutus's applications to extend deadlines for filing their reply to the defence and statement of defence in counterclaim, following delayed access to confidential information in the Moderna mRNA patent infringement proceedings.
Legal issues:Extension of time limits (Rule 9.3 RoP)Reply deadline after confidentiality orderCounterclaim for revocation procedure

Documents